Neelufar Mozaffarian

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Neelufar Mozaffarian

Earlier roles on record: Board Member at Fate Therapeutics Inc (FATE) until October 13, 2025. Fate Therapeutics Inc reported in an 8-K filed October 14, 2025 that Neelufar Mozaffarian resigned as Board, effective October 13, 2025.

“On October 10, 2025, John D. Mendlein, Ph.D., J.D. and Neelufar Mozaffarian, M.D., Ph.D., FACR each provided notice of their respective resignation from the Board, effective as of October 13, 2025.”

Fate Therapeutics Inc Form 8-K, filed October 14, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Neelufar Mozaffarian's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Fate Therapeutics Inc (FATE)
Board Member

Proxy statement

Start not stated–2025-10-13

Company network

Recorded roles and call appearances connecting this person to public companies.

Fate Therapeutics Inc

FATE

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Board Fate Therapeutics Inc (FATE)
2025-10-13